On May 7, 2025, the US District Court for the Northern District of Texas upheld the US Food and Drug Administration’s (FDA’s) decision to remove two tirzepatide injection medications from the FDA’s drug shortage list. This...more
6/13/2025
/ Appeals ,
Drug Compounding ,
Enforcement Actions ,
Food and Drug Administration (FDA) ,
Healthcare ,
Healthcare Reform ,
Judicial Authority ,
Pharmaceutical Industry ,
Prescription Drugs ,
Regulatory Agenda ,
Regulatory Reform ,
Regulatory Requirements ,
Supply Shortages
On February 21, 2025, the US Food and Drug Administration (FDA) revised its shortage categorization of semaglutide, a glucagon-like peptide 1 (GLP-1) medication, marking the shortage as “resolved” for all presentations of the...more
On October 3, 2024, the US Food and Drug Administration (FDA) revised its shortage categorization of tirzepatide, a glucagon-like peptide 1 (GLP-1) medication, marking the shortage as “resolved” for all presentations of the...more
10/10/2024
/ Drug Compounding ,
Food and Drug Administration (FDA) ,
Goods or Services ,
Healthcare ,
Life Sciences ,
Patient Access ,
Pharmaceutical Industry ,
Pharmacies ,
Prescription Drugs ,
Supply Chain ,
Supply Shortages
Trending in Telehealth highlights state legislative and regulatory developments that impact the healthcare providers, telehealth and digital health companies, pharmacists and technology companies that deliver and facilitate...more
2/12/2024
/ Digital Health ,
Health Care Providers ,
Healthcare ,
Healthcare Reform ,
Legislative Agendas ,
Pharmaceutical Industry ,
Regulatory Agenda ,
State and Local Government ,
Technology ,
Telehealth ,
Telemedicine
Trending in Telehealth highlights state legislative and regulatory developments that impact the healthcare providers, telehealth and digital health companies, pharmacists and technology companies that deliver and facilitate...more
McDermott’s digital health team continually monitors legal developments affecting all aspects of the remote delivery of care. This inaugural issue of our Of Digital Interest Quarterly Roundup highlights key issues and trends...more
4/28/2023
/ Banking Sector ,
Controlled Substances ,
DEA ,
Digital Health ,
Financial Crisis ,
Health Care Providers ,
Pharmaceutical Industry ,
Prescription Drugs ,
Proposed Rules ,
Regulatory Agenda ,
Rulemaking Process ,
Silicon Valley ,
State and Local Government ,
Telehealth ,
Telemedicine
On February 24, 2023, the US Drug Enforcement Administration (DEA) issued two proposed rules (the Telemedicine Controlled Substance Proposed Rule and the Telemedicine Buprenorphine Proposed Rule) that would establish...more
Maintain Connections with Healthcare Leaders. Stay Current on Market Trends. Look Ahead to 2021 and Beyond.
Join us virtually for McDermott's signature HPE New York conference. We'll bring together preeminent healthcare...more
10/14/2020
/ Ambulatory Surgery Centers ,
Banking Sector ,
Coronavirus/COVID-19 ,
Digital Health ,
Food and Drug Administration (FDA) ,
Health Care Providers ,
Health Information Technologies ,
Home Health Care ,
Hospice ,
Infectious Diseases ,
Investment Banks ,
Investors ,
Legislative Agendas ,
Medical Reimbursement ,
Mental Health ,
Pharmaceutical Industry ,
Physical Therapists ,
Physicians ,
Private Equity ,
Private Equity Firms ,
Private Equity Funds ,
Vaccinations ,
Webinars
Maintain Connections with Healthcare Leaders. Stay Current on Market Trends. Look Ahead to 2021 and Beyond.
Join us virtually for McDermott's signature HPE New York conference. We'll bring together preeminent healthcare...more
10/13/2020
/ Ambulatory Surgery Centers ,
Banking Sector ,
Coronavirus/COVID-19 ,
Digital Health ,
Food and Drug Administration (FDA) ,
Health Care Providers ,
Health Information Technologies ,
Home Health Care ,
Hospice ,
Infectious Diseases ,
Investment Banks ,
Investors ,
Legislative Agendas ,
Medical Reimbursement ,
Mental Health ,
Pharmaceutical Industry ,
Physical Therapists ,
Physicians ,
Private Equity ,
Private Equity Firms ,
Private Equity Funds ,
Vaccinations ,
Webinars
Maintain Connections with Healthcare Leaders. Stay Current on Market Trends. Look Ahead to 2021 and Beyond.
Join us virtually for McDermott's signature HPE New York conference. We'll bring together preeminent healthcare...more
10/7/2020
/ Ambulatory Surgery Centers ,
Banking Sector ,
Coronavirus/COVID-19 ,
Digital Health ,
Food and Drug Administration (FDA) ,
Health Care Providers ,
Health Information Technologies ,
Home Health Care ,
Hospice ,
Infectious Diseases ,
Investment Banks ,
Investors ,
Legislative Agendas ,
Medical Reimbursement ,
Mental Health ,
Pharmaceutical Industry ,
Physical Therapists ,
Physicians ,
Private Equity ,
Private Equity Firms ,
Private Equity Funds ,
Vaccinations ,
Webinars
HPE New York brings together preeminent healthcare private equity executives and investment bankers and unmatched keynote speakers to your remote workspace in a cutting-edge format – unlike any other conference this...more
10/6/2020
/ Ambulatory Surgery Centers ,
Banking Sector ,
Coronavirus/COVID-19 ,
Digital Health ,
Food and Drug Administration (FDA) ,
Health Care Providers ,
Health Information Technologies ,
Home Health Care ,
Hospice ,
Infectious Diseases ,
Investment Banks ,
Investors ,
Legislative Agendas ,
Medical Reimbursement ,
Mental Health ,
Pharmaceutical Industry ,
Physical Therapists ,
Physicians ,
Private Equity ,
Private Equity Firms ,
Private Equity Funds ,
Vaccinations ,
Webinars
On December 7, 2016, the US Congress enacted the 21st Century Cures Act, substantial legislation intended to accelerate “discovery, development and delivery” of medical therapies by encouraging biomedical research investment,...more
1/21/2017
/ 21st Century Cures Act ,
Ambulatory Surgery Centers ,
Digital Health ,
Food and Drug Administration (FDA) ,
Health Care Providers ,
Health Information Technologies ,
Health Insurance Portability and Accountability Act (HIPAA) ,
Hospitals ,
Long Term Care Facilities ,
Manufacturers ,
Medical Devices ,
Medicare ,
Medicare Advantage ,
MedPAC ,
Mental Health ,
Mental Health Parity Rule ,
National Institute of Health (NIH) ,
Off-Campus Departments ,
Opioid ,
Patients ,
Pharmaceutical Industry ,
Research and Development ,
Small Business ,
Substance Abuse ,
Telehealth ,
Transparency